Growth hormone secretagogues like CJC-1295, ipamorelin, and the GHRPs are typically evaluated using a specific set of laboratory measurements, and understanding what those measurements actually capture, and don't, is useful for interpreting claims about these compounds.
Growth Hormone Level Measurement
The most direct measurement is serum growth hormone level, typically drawn at multiple time points after administration to capture the pulse of release these compounds are designed to trigger, since growth hormone is naturally released in pulses rather than at a constant level throughout the day.
IGF-1 as a More Stable Marker
Because growth hormone itself fluctuates rapidly and has a short half-life, researchers often rely more heavily on IGF-1 (insulin-like growth factor 1), which growth hormone stimulates the liver to produce, as a more stable, integrated marker of growth hormone activity over time, since IGF-1 levels don't swing as dramatically hour to hour.
What These Markers Do and Don't Show
A study showing a secretagogue reliably raises growth hormone or IGF-1 levels is measuring a real, meaningful biological effect, but it's a different question from whether that hormonal change translates into a specific outcome someone might actually care about, like increased muscle mass, improved recovery, or better sleep, which requires separate outcome-specific research beyond the hormone measurements alone.
The Gap Between Hormonal Effect and Functional Outcome
This is a common pattern across the growth hormone secretagogue category: reasonably solid evidence that these compounds do what they're pharmacologically designed to do, raise growth hormone and IGF-1, paired with much thinner evidence connecting that hormonal change to the specific downstream benefits, body composition, recovery, longevity, that are actually driving most people's interest in them.
The Bottom Line
When a study or marketing claim cites "increased growth hormone levels" as evidence a secretagogue works, it's worth recognizing that as evidence of the compound's direct pharmacological action, which is real and measurable, not necessarily as evidence for whatever downstream benefit is actually being promised, which often requires its own separate, and often missing, body of research.
Why Timing of Blood Draws Matters
Because growth hormone is released in short pulses rather than continuously, the specific timing of blood draws relative to dosing has a significant effect on measured levels, and studies that don't carefully standardize this timing can produce results that are hard to compare directly to other research on the same compound, an easy-to-overlook methodological detail that meaningfully affects how reliable and comparable a given secretagogue study's findings actually are.